Simone Saibeni to Humans
This is a "connection" page, showing publications Simone Saibeni has written about Humans.
Connection Strength
0.088
-
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European Gastroenterol J. 2020 12; 8(10):1228-1235.
Score: 0.007
-
Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 09 18; 26(10):e107-e109.
Score: 0.007
-
Proposal for returning to routine endoscopy during the COVID-19 pandemic: what is really feasible? Endoscopy. 2020 09; 52(9):815.
Score: 0.007
-
Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities. Dig Liver Dis. 2020 08; 52(8):823-828.
Score: 0.007
-
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds. Gut. 2021 03; 70(3):623-624.
Score: 0.007
-
Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist. Gastroenterology. 2021 06; 160(7):2625-2626.
Score: 0.007
-
A safety evaluation of budesonide MMX for the treatment of ulcerative colitis. Expert Opin Drug Saf. 2018 Apr; 17(4):437-444.
Score: 0.006
-
Endoscopy for patients affected by inflammatory bowel disease: bowel preparation and sedation. Expert Rev Gastroenterol Hepatol. 2018 Feb; 12(2):119-124.
Score: 0.006
-
New horizons in the imaging of perianal Crohn's disease: transperineal ultrasonography. Expert Rev Gastroenterol Hepatol. 2017 Jun; 11(6):523-530.
Score: 0.006
-
Aspecific ileitis: Crohn's disease or not Crohn's disease? A prospective study. Int J Colorectal Dis. 2017 Jul; 32(7):1025-1028.
Score: 0.006
-
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. J Gastroenterol Hepatol. 2021 Nov; 36(11):3050-3055.
Score: 0.002
-
Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study. Am J Gastroenterol. 2021 02 01; 116(2):306-310.
Score: 0.002
-
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population. Dig Liver Dis. 2021 03; 53(3):263-270.
Score: 0.002
-
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey. Inflamm Bowel Dis. 2020 10 23; 26(11):e134-e136.
Score: 0.002
-
Improvement in appropriateness and diagnostic yield of fast-track endoscopy during the COVID-19 pandemic in Northern Italy. Endoscopy. 2021 Feb; 53(2):162-165.
Score: 0.002
-
Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect. Gastroenterology. 2021 05; 160(6):2196-2197.
Score: 0.002
-
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020 07; 69(7):1213-1217.
Score: 0.002
-
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1361-1369.
Score: 0.002
-
Unmet needs of Italian physicians managing patients with inflammatory bowel disease. Dig Liver Dis. 2019 02; 51(2):212-217.
Score: 0.002
-
Anti-tumour necrosis factor-a antibodies and B cell homeostasis in human inflammatory bowel diseases. Int Immunopharmacol. 2018 Jan; 54:329-335.
Score: 0.001
-
The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey. Dig Liver Dis. 2017 Oct; 49(10):1092-1097.
Score: 0.001
-
Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence. Expert Rev Gastroenterol Hepatol. 2017 Apr; 11(4):339-347.
Score: 0.001
-
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis. 2017 04; 49(4):338-358.
Score: 0.001